Abstract：
SARS-CoV-2 continues to mutate with the emergence of new variants. Variant B.1.617.2 (Delta) is a variant of concern with evidence of increased transmission, more severe disease, decreased effectiveness of treatment or vaccines, or failure of diagnostic detection. In this article, we report on the clinical and biological picture of the first confirmed delta variant COVID-19 infection in Indonesia. From May 31 to June 17, we identified ten cases with confirmed delta variant COVID-19 infection admitted to a tertiary academic hospital in Jakarta. All subjects that have been vaccinated presented with mild-moderate disease. Most patients present with initial respiratory complaints, without radiological abnormalities on chest x-ray examination, and an increase in C-reactive protein. Seven out of ten patients have been vaccinated; the three patients who had not been vaccinated experienced severe COVID-19 symptoms, two of whom died. Due to the increased transmission of this variant, we recommend vaccination, wearing a mask, and social distancing to reduce the impact of infection with delta variant B.1,617.2.
摘要：
SARS-CoV-2随着新变体的出现而继续突变。备选案文B.1.617.2(Delta)是一个令人关注的变体,有证据表明传播增加,更严重的疾病，治疗或疫苗的有效性下降，或诊断检测失败。在这篇文章中,我们报道了印度尼西亚首例确诊的delta变异型COVID-19感染的临床和生物学情况。从5月31日至6月17日，我们确定了雅加达一家三级学术医院收治的10例确诊的三角洲变异型COVID-19感染病例。已接种疫苗的所有受试者均患有轻度-中度疾病。大多数患者出现初始呼吸不适，胸部X线检查无放射学异常，和C反应蛋白的增加。十分之七的患者已接种疫苗；未接种疫苗的三名患者出现严重的COVID-19症状，其中两人死亡。由于此变体的传输增加，我们建议接种疫苗，戴着面具,和社交距离，以减少感染三角洲变异B.1,617.2的影响。
